IN VIVO ANTI-CD3-DRIVEN CELL ACTIVATION

This publication has 31 references indexed in Scilit:

• Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
  Journal of Clinical Investigation, 1994
• CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.
  The Journal of Experimental Medicine, 1994
• In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A.
  The Journal of Experimental Medicine, 1993
• EVIDENCE THAT ANTIHUMAN TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY PREVENTS OKT3-INDUCED ACUTE SYNDROME
  Transplantation, 1992
• Inter-mouse strain differences in thein vivoanti-CD3 induced cytokine release
  Clinical and Experimental Immunology, 1991
• Cascade modulation by anti‐tumor necrosis factor monoclonal antibody of interferon‐γ, interleukin 3 and interleukin 6 release after triggering of the CD33/T cell receptor activation pathway
  European Journal of Immunology, 1991
• IN VIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION
  Transplantation, 1990
• Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation
  European Journal of Immunology, 1990
• Hypothermia and hypoglycemia induced by anti‐CD3 monoclonal antibody in mice: Role of tumor necrosis factor
  European Journal of Immunology, 1990
• RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS
  Transplantation, 1989